Please try another search
For the fiscal year ended 31 December 2017, Bioamber Inc revenues increased 81% to $14.9M. Net loss increased from $22.5M to $98.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Impairment increase from $0K to $77.6M (expense), Grant income decrease of 91% to $359K (income).
Period Ending: | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 |
---|---|---|---|---|
Total Revenue | 5.4 | 3.3 | 4.12 | 2.12 |
Gross Profit | -1.1 | -2.68 | -1.61 | -1.99 |
Operating Income | -83.51 | -8.08 | -7.8 | -9.88 |
Net Income | -84.07 | -7.05 | -7.14 | 0.11 |
Period Ending: | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 |
---|---|---|---|---|
Total Assets | 69.51 | 155.52 | 147.57 | 150.73 |
Total Liabilities | 47.66 | 48.73 | 78.55 | 85.64 |
Total Equity | 21.85 | 106.79 | 69.02 | 65.1 |
Period Ending: | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 |
---|---|---|---|---|
Period Length: | 12 Months | 9 Months | 6 Months | 3 Months |
Cash From Operating Activities | -29.79 | -24.54 | -18.77 | -10.61 |
Cash From Investing Activities | -0.81 | -0.72 | -0.43 | -0.25 |
Cash From Financing Activities | 18.85 | 19.05 | 8.64 | -0.02 |
Net Change in Cash | -11.53 | -5.93 | -10.42 | -10.85 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review